Automatic CPR devices market seen topping $2 billion by 2030

The global automatic cardiopulmonary resuscitation devices market is projected to grow at an 11.8% CAGR and exceed $2 billion by 2030, according to The Business Research Company. North America is expected to lead the market, while piston-based mechanical CPR devices are forecast to remain the largest product segment.

Why it matters: - Automatic CPR devices are becoming a bigger part of emergency cardiac care as hospitals, ambulances and first responders look for more consistent chest compressions during critical events. - The market is expected to exceed $2 billion by 2030, signaling broader adoption across pre-hospital and in-hospital care. - The segment sits inside a much larger resuscitation devices market projected to reach about $15 billion by 2030.

What happened: - The Business Research Company released its Automatic Cardiopulmonary Resuscitation Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Oct. 26, 2026. - The report projects the global automatic CPR devices market will grow at an 11.8% CAGR. - The report also says the market will reach more than $2 billion by 2030. - North America is projected to be the largest regional market in 2030 at $0.57 billion. - The United States is expected to be the largest country market in 2030 at $0.50 billion.

The details: - Automatic CPR devices are projected to account for about 12% of the broader resuscitation devices market by 2030. - Within the wider medical equipment industry, the segment will represent roughly 0.1% of the $1,176 billion market projected for 2030. - The market includes piston-based mechanical CPR devices, load-distributing band devices, pneumatic compression vest systems, active compression-decompression devices and automated external defibrillators with CPR assist features. - Piston-based mechanical CPR devices are projected to lead the market with about 40% share, or $1 billion, by 2030. - The report says piston-based systems are favored for consistent compressions during transport, hands-free resuscitation, compatibility with advanced cardiac life support protocols and use in extended resuscitation. - The market is also segmented by portability, technology, application and end user. - Portability splits the market into portable and fixed devices. - Technology segments include mechanical, electromechanical and robotic systems. - Applications include out-of-hospital cardiac arrest, in-hospital cardiac arrest, respiratory failure with secondary cardiac compromise, trauma-related arrest, post-surgical cardiac support and mass-casualty events. - End users include hospitals, emergency medical services, ambulatory surgical centers, public access and first responder units, and home care settings. - In North America, the market is expected to grow from $0.34 billion in 2025 to $0.57 billion in 2030, a CAGR of 11%. - In the United States, the market is forecast to rise from $0.30 billion in 2025 to $0.50 billion in 2030, also at 11% CAGR.

Between the lines: - The report points to three main growth drivers: rising cardiac arrest incidents, broader adoption by EMS and hospitals, and greater awareness of early resuscitation. - Aging populations, higher cardiovascular disease prevalence and lifestyle-related health conditions are adding to demand. - Health systems are using automated CPR devices to standardize resuscitation quality and free staff for other interventions during emergencies. - The report attributes roughly 2.8% annual growth to rising cardiac arrest incidents, about 2.5% to EMS and hospital adoption, and around 2.3% to growing awareness and CPR training. - The market is moderately concentrated, with the top 10 companies accounting for about 35% of 2025 revenue. - That concentration reflects regulatory hurdles, clinical adoption challenges and the specialized nature of the technology. - Stryker Corporation led global sales in 2025 with a 16% share. - ZOLL Medical Corporation held 8%, while Schiller AG and Nihon Kohden Corporation each held 3%. - Other listed players include Bexen Cardio, Mediana, SunLife Science, Shenzhen Bangvo Technology, Inovytec Medical Solutions, AAT Alber Antriebstechnik, Faith Biotech, corpuls, CPR Therapeutics, Landswick Medical Technology and Michigan Instruments.

What's next: - The report says opportunities through 2030 are concentrated in piston-based systems, load-distributing band devices, pneumatic compression vest systems, active compression-decompression devices and AEDs with CPR assist features. - Together, those categories are projected to generate more than $0.74 billion in market value by 2030. - The report expects product innovation to focus on portability, user-friendliness, battery efficiency, smart connectivity and real-time monitoring. - Companies are also expected to expand through partnerships, distribution deals and geographic growth. - Air Methods Corporation introduced the ZOLL AutoPulse NXT in May 2025 for air medical missions, highlighting continued product development in the category.

The bottom line: - Automatic CPR devices are moving from a niche emergency-care tool into a larger global growth market, with hospitals, EMS providers and manufacturers all pushing for faster, more reliable resuscitation.